Remote patient monitoring, one of the great promises of the digital revolution in medicine, was chosen from a field of 16 submissions and won the prestigious Industry Innovation Award by the American Association of Hip and Knee Surgeons (AAHKS) at the organization’s recent annual meeting in Dallas, Texas.
Remote Patient Monitoring Wins AAHKS’s 2023 Innovation Award

The company that developed this digital technology, 13-year-old, New York City-based Force Therapeutics LLC, was founded by a former physical therapist with more than 20 years of clinical physical therapy experience. The founder, Bronwyn Spira, understood the challenges for patients who had been sent home with vague care instructions and stick figure drawings, but ended up struggling with recovery at home. Her belief, and it is the reason she founded Force Therapeutics, is that empowering patients with the right education and communication can take a lot of cost out of the system and, most importantly, improve patient outcomes.
Amen.
“AAHKS is truly excited to grant the Industry Innovation Award to Force Therapeutics for its addition of Remote Therapeutic Monitoring (RTM) to its digital care platform. It’s very important for industry to have a role in developing innovations in patient care and with 16 entries submitted, I think that’s a great indicator for innovation in the field of hip and knee arthroplasty,” said Javad Parvizi, M.D., FRCS, AAHKS President.
Company CEO Bronwyn Spira told OTW, “At Force Therapeutics, our mission is to improve patient outcomes and provider efficiency while reducing the overall cost of care.”
“As the leading MSK patient engagement platform, Force Therapeutics is uniquely equipped to optimize digital care and RTM reimbursement, resulting in strong patient outcomes and satisfaction, while reducing costly barriers, improving access to care and optimizing provider workflows.”
“The 2023 AAHKS Industry Innovation Award is validation that our advanced platform innovations continue to provide high quality improvements for both patients and surgeons and is in sync with what the Orthopedic market needs.”
“Our RTM solution allows health systems, physician practices, and ambulatory surgical centers to provide patients with virtual physical therapy and remote monitoring that adheres to CMS [Centers for Medicare and Medicaid Services] guidelines. Our provider-prescribed digital care management platform is validated to provide compliant documentation for the new RTM Current Procedural Terminology (CPT) codes finalized by the Centers for Medicare and Medicaid Services,” added Spira.
“It is a powerful tool, with deep clinical intelligence, that scales workflows and maximizes care teams to drastically improve efficiency, profitability, and set a new standard of high-quality care.”
Finally, said Spira, “Our system engages both patients and providers, enabling robust real-time data collection and actionable insights to produce the most effective patient care and the most efficient provider workflows possible. By automating routine touch points and tasks, Force Therapeutics enables clinical care teams to intelligently monitor and interact with patients throughout their care journey.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.